DOCSLIB.ORG

Eltrombopag-Associated Hyperpigmentation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Eltrombopag-Associated Hyperpigmentation Letters Figure 2. Histopathologic Findings A B C D A, Black-brown deposits in the upper and deep dermis (hematoxylin-eosin, original magnification ×10). B, Panoramic view in which deposits are positively stained in superficial and deep layers (Perls stain, original magnification ×4). C, Interstitial and perivascular deposits positively stained with this argent technique (Masson-Fontana stain, original magnification ×40). D, Deposits corresponding to an exogenous material inside lysosomes of fibroblasts (ultrastructural study). confined to scars or sites with previous inflammation or Author Affiliations: Department of Dermatology, Hospital Universitario de trauma. In type 2, blue-gray pigmentation occurs within pre- Guadalajara, Spain (Lorente, Ballano, Juanes, Pastor); Department of Pathology, Hospital Universitario de Guadalajara, Spain (Cuevas). viously normal-appearing skin, especially in the lower legs and Corresponding Author: Mónica Lorente, MD, Donantes de Sangre s/n, E-19002 forearms. Type 3 is characterized by the presence of diffuse Guadalajara, Spain ([email protected]; [email protected]). brownish discoloration of sun-exposed areas. Histopathologi- Published Online: July 3, 2013. cally, types 1 and 2 demonstrate pigment granules in the der- doi:10.1001/jamadermatol.2013.4365. mis, concentrated around vasculature within macrophages, Conflict of Interest Disclosures: None reported. and, in type 2, around myoepithelial cells as well. Perls stain- Additional Contributions: Special thanks to Miguel Angel Martínez, MD, ing is positive in type 1. In type 2, both Perls and Masson- Hospital 12 de Octubre, Madrid, for ultrastructural study. Fontana stainings are positive. In type 3, there is increased 1. Liu HH. Safety profile of the fluoroquinolones: focus on levofloxacin. Drug melanin in basal keratinocytes with subjacent dermal mela- Saf. 2010;33(5):353-369. nophages without the presence of iron. Only Masson- 2. López-Pestaña A, Tuneu A, Lobo C, Zubizarreta J, Eguino P. Blue-black Fontana staining is positive in this type.4 pigmentation of legs and arms in a 68-year-old woman. Arch Dermatol. 2007;143(11):1441-1446. Ultrastructural observations have confirmed that the clini- 3. Le Cleach L, Chosidow O, Peytavin G, et al. Blue-black pigmentation cal coloration is a result of a minocycline derivative chelated of the legs associated with pefloxacin therapy. Arch Dermatol. with iron that is stored within the lysosomes of macro- 1995;131(7):856-857. phages. To our knowledge, there are no reports of cutaneous 4. Bowen AR, McCalmont TH. The histopathology of subcutaneous pigmentation due to rifampicin. Our patient’s symptoms and minocycline pigmentation. J Am Acad Dermatol. 2007;57(5):836-839. the histologic findings were similar to those described for mi- 5. Green D, Friedman KJ. Treatment of minocycline-induced cutaneous nocycline pigmentation type 2 and previous cases associated pigmentation with the Q-switched Alexandrite laser and a review of the literature. J Am Acad Dermatol. 2001;44(2)(suppl):342-347. with levofloxacin and pefloxacin. The course of the pigmentation is unknown, but it tends to fade if levofloxacin treatment is discontinued. Months or Eltrombopag-Associated Hyperpigmentation years are necessary to achieve resolution, although in some We report 2 cases of cutaneous hyperpigmentation with cases the pigmentation can be permanent. Treatment with Q- eltrombopag, a novel thrombopoietin receptor agonist. switched laser has been reported with successful results.5 Report of Cases | Case 1. A 69-year-old white woman with re- Mónica Lorente, MD fractory acute myelogenous leukemia (AML) was referred to der- Adrián Ballano, MD matology for skin graying. Treatment with eltrombopag, 300 Adriana Juanes, MD mg/d, was initiated in a clinical trial.1 After 3 months, the pa- Maria Antonia Pastor, MD tient’s husband and clinical team noted gray hyperpigmenta- Jesús Cuevas, MD tion predominantly affecting the face (Figure 1A). She had re- 1112 JAMA Dermatology September 2013 Volume 149, Number 9 jamadermatology.com Downloaded From: https://jamanetwork.com/ on 09/28/2021 Letters Figure 1. Images From Case 1 A B C D A, Clinical photograph of patient 1 demonstrates subtle gray discoloration of the magnification ×600). C and D, This pigment was highlighted by face compared with the patient’s hands. B, Histopathologic image Fontana-Masson stain (C) (original magnification ×600) and stained weakly demonstrates brown granules of pigmentation (hematoxylin-eosin, original positive with Prussian blue (D) (original magnification ×600). ceived cytarabine and daunorubicin 10 weeks prior to In addition to deep neutrophilic inflammation, there was eltrombopag and sirolimus and mitoxantrone 5 weeks prior to prominent pigment deposition in the mid to deep dermis stain- eltrombopag. The hands, nails, sclera, and mucosa were unin- ing positive with both Fontana-Masson and Prussian blue stains volved. Histopathologic examination of preauricular skin dem- (Figure 2). The pigmentation remained stable 3 months into onstrated mild inflammation and focal dermal pigment that eltrombopag therapy. The patient, her husband, and the on- stained positive with Fontana-Masson and weakly positive with cology team believed that she was notably darker than before Prussian blue (Figure 1B-D). The pigmentation remained stable beginning eltrombopag treatment, and on comparison with a over the subsequent 8 months during eltrombopag treatment. family photograph, the patient’s skin was believed to be darker than baseline by the dermatology team. Case 2. A 66-year-old woman of mixed white, African, and Na- tive American descent with refractory AML developed dark- Discussion | Eltrombopag is a novel, nonpeptide thrombopoi- ening of her skin during treatment with eltrombopag. She had etin receptor agonist approved for treatment of chronic idio- received cytarabine and daunorubicin 3 months prior to ini- pathic thrombocytopenic purpura (ITP). It has also recently been tiating a clinical trial with eltrombopag. Two months after start- approved for the treatment of hepatitis C associated ing eltrombopag therapy, the dermatology consult team was thrombocytopenia2 and is currently being used in clinical trials called to evaluate subcutaneous nodules clinically sugges- for AML and myelodysplastic syndromes. Reported cutaneous tive of Sweet syndrome. At that time she was noted to have a adverse effects have been minimal. Pruritic exanthema have diffuse dusky complexion involving her face, arms, and legs. been reported in 3 patients taking eltrombopag, 25 to 50 mg/d, A biopsy of a subcutaneous nodule on her leg was performed. for ITP.3 In vitro studies suggest a theoretical phototoxic effect jamadermatology.com JAMA Dermatology September 2013 Volume 149, Number 9 1113 Downloaded From: https://jamanetwork.com/ on 09/28/2021 Letters Figure 2. Histopathologic Images From Case 2 With Diffuse Pigment Deposition A B C D A, Low magnification demonstrates pigmentation throughout the dermis and in (hematoxylin-eosin, original magnification ×600) that stain strongly positive superficial subcutaneous tissue (hematoxylin-eosin, original magnification with Fontana-Masson (C) (original magnification ×600) and Prussian blue ×40). B-D, Higher magnification shows multiple foci of brown fine granules (B) (original magnification ×600). of eltrombopag; however, a clinical study of eltrombopag, 300 those agents. Additionally,the lack of inflammation or erythema mg/d (75 mg 4 times daily) for 6 days, failed to show increased in the skin, along with the presence of both hemosiderin and photosensitivity.4 To our knowledge, this is the first report of Fontana-Masson–positive material, supports a drug-associated cutaneous hyperpigmentation associated with eltrombopag. hyperpigmentation rather than postinflammatory hyperpigmen- Numerous medications are associated with drug-induced tation. The hyperpigmentation in case 1 appeared photodistrib- hyperpigmentation, including minocycline, amiodarone, and uted, which, along with the superficial pigmentary deposits, may chemotherapeutic agents including novel targeted therapies.5,6 implicate phototoxic effects in the pathogenesis. The pathogenesis behind medication-associated hyperpigmen- We describe the novel finding of cutaneous hyperpigmen- tation remains unclear. Some attribute increased melanin dep- tation associated with eltrombopag and the associated patho- osition (measured by Fontana-Masson staining) to increased logic findings. Further investigation is needed to better char- melanin production stimulated directly by the medication or acterize this phenomenon. indirectly by inflammation related to the medication. Like- wise, hemosiderin deposition (seen with Prussian blue stain- Inbal Braunstein, MD ing) is postulated to arise from red blood cell leakage (1) from Karolyn A. Wanat, MD direct vessel damage caused by the drug, (2) secondary to in- Rosalie Elenitsas, MD flammation related to the drug or (3) due to deposition of spe- XiaoWei Xu, MD, PhD cific pigments related to the drug.6 Noelle Frey, MD Although some of the other chemotherapeutic agents used Misha Rosenbach, MD previously in the patients have been associated with hyperpig- mentation, the onset of the clinical graying in our patients oc- Author Affiliations: Department of Dermatology, Perelman School of Medicine, curred more than 10 weeks after discontinuing treatment with University of Pennsylvania, Philadelphia (Braunstein, Wanat, Elenitsas, Xu, 1114 JAMA Dermatology
Load more

Recommended publications
  • Health Sciences Center
    Faculty of Allied Health Sciences Handbook: 2020-2021 KUWAIT UNIVERSITY HEALTH SCIENCES CENTRE 1 | P a g e KUWAIT UNIVERSITY HEALTH SCIENCES CENTRE FACULTY OF ALLIED HEALTH SCIENCES Established: 1982 HANDBOOK 2020-2021 2 | P a g e Department of MEDICAL LABORATORY SCIENCES [MLS] 3 | P a g e DEPARTMENT OF MEDICAL LABORATORY SCIENCES Medical Laboratory Sciences offers opportunities for those interested in biological and chemical sciences, leading to a career in the health service or in research. Medical laboratory scientists are professionals who perform laboratory tests and analyses that assist physicians in the diagnosis and treatment of patients. They also assist in research and the development of new laboratory tests. The various studies include chemical and physical analysis of body fluids (clinical chemistry and urinalysis); examination of blood and its component cells (haematology); isolation and identification of bacteria, fungi, viruses and parasites (clinical microbiology and parasitology); testing of blood serum for antibodies indicative of specific diseases (immunology and serology) and collection, storage of blood, pretransfusion testing and other immunohaematological procedures (blood banking). In addition, medical laboratory scientists prepare tissues for histopathological, cytological and cytogenetic examination. They must know the theory and scientific fundamentals as well as the procedures for testing. Medical laboratory scientists work in hospital clinical laboratories, medical schools, research institutions, public health agencies and related organizations. MISSION AND OBJECTIVES Mission The mission of the Department of Medical Laboratory Sciences is to educate and train skillful, knowledgeable and committed Medical Laboratory Scientists who have breadth of knowledge and competence in the various aspects of Medical Laboratory Sciences, who shall adhere to professional ethics, and who can contribute successfully as Medical Laboratory Scientists in the health care team.
    [Show full text]
  • Two Cases of Nevoid Basal Cell Carcinoma Syndrome in One Family
    221 Two Cases of Nevoid Basal Cell Carcinoma Syndrome in One Family Dong Jin Ryu, M.D., Yeon Sook Kwon, M.D., Mi Ryung Roh, M.D., Min-Geol Lee, M.D., Ph.D. Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea The nevoid basal cell carcinoma syndrome, or Gorlin-Goltz syndrome, is an autosomal dominant multiple system disorder with high penetrance and variable expressions, although it can also arise spontaneously. The diagnostic criteria for nevoid basal cell carcinoma syndrome include multiple basal cell carcinomas, palmoplantar pits, multiple odontogenic keratocysts, skeletal anomalies, positive family history, ectopic calcification and neurological anomalies. We report a brother and sister who were both diagnosed with nevoid basal cell carcinoma syndrome. (Ann Dermatol (Seoul) 20(4) 221∼225, 2008) Key Words: Basal cell carcinoma, Nevoid basal cell carcinoma syndrome, Odontogenic keratocyst INTRODUCTION cell carcinoma syndrome. The nevoid basal cell carcinoma syndrome (NBCCS), or Gorlin-Goltz syndrome, is an auto- CASE REPORT somal dominant multiple system disorder with high 1 penetrance and variable expressions . However, Case 1 60% of patients with NBCCS are sporadic cases. It An 11-year-old male was referred to our depart- has an estimated prevalence of 1 in 60,000 with ment for the evaluation of multiple miliary sized 2 equal distributions among males and females . The pigmented macules on the palm and sole that had well-defined diagnostic criteria include cutaneous increased in number over several years. He had an anomalies, dento-facial anomalies, skeletal ano- operation for inguinal hernia at 3 years of age, but malies, positive family history, neurological ano- no other medical problems.
    [Show full text]
  • Acquired Bilateral Nevus of Ota–Like Macules (Hori's Nevus): a Case
    Acquired Bilateral Nevus of Ota–like Macules (Hori’s Nevus): A Case Report and Treatment Update Jamie Hale, DO,* David Dorton, DO,** Kaisa van der Kooi, MD*** *Dermatology Resident, 2nd year, Largo Medical Center/NSUCOM, Largo, FL **Dermatologist, Teaching Faculty, Largo Medical Center/NSUCOM, Largo, FL ***Dermatopathologist, Teaching Faculty, Largo Medical Center/NSUCOM, Largo, FL Abstract This is a case of a 71-year-old African American female who presented with bilateral periorbital hyperpigmentation. After failing treatment with a topical retinoid and hydroquinone, a biopsy was performed and was consistent with acquired bilateral nevus of Ota-like macules, or Hori’s nevus. A review of histopathology, etiology, and treatment is discussed below. cream and tretinoin 0.05% gel. At this visit, a Introduction Figure 2 Acquired nevus of Ota-like macules (ABNOM), punch biopsy of her left zygoma was performed. or Hori’s nevus, clinically presents as bilateral, Histopathology reported sparse proliferation blue-gray to gray-brown macules of the zygomatic of irregularly shaped, haphazardly arranged melanocytes extending from the superficial area. It less often presents on the forehead, upper reticular dermis to mid-deep reticular dermis outer eyelids, and nose.1 It is most common in women of Asian descent and has been reported Figure 4 in ages 20 to 70. Classically, the eye and oral mucosa are uninvolved. This condition is commonly misdiagnosed as melasma.1 The etiology of this condition is not fully understood, and therefore no standardized treatment has been Figure 3 established. Case Report A 71-year-old African American female initially presented with a two week history of a pruritic, flaky rash with discoloration of her face.
    [Show full text]
  • Co-Occurrence of Vitiligo and Becker's Nevus: a Case Report
    Case Report Olgu Sunumu DOI: 10.4274/turkderm.71354 Turkderm - Arch Turk Dermatol Venerology 2016;50 Co-occurrence of vitiligo and Becker's nevus: A case report Vitiligo ve Becker nevüs birlikteliği: Olgu sunumu Ayşegül Yalçınkaya İyidal, Özge Çokbankir*, Arzu Kılıç** Ağrı State Hospital, Clinic of Dermatology, *Clinic of Pathology, Ağrı, Turkey **Balıkesir University Faculty of Medicine, Department of Dermatology, Balıkesir, Turkey Abstract Vitiligo is an acquired disorder with an unknown etiology in which genetic and non-genetic factors coexist. Melanocytes are destructed in the affected skin areas and clinically depigmented macules and patches appear on the skin. Becker's nevus (BN) appears as hyperpigmented macule, patch or verrucous plaques with sharp and irregular margins and often unilateral occurrence and with associated hypertrichosis in various degrees. Although its pathogenesis is unknown, it is suggested to represent a hamartomatous lesion harboring androgen receptors on the lesion. In this report, we present a 19-year-old male patient who developed vitiligo lesions and then BN adjacent to the vitiligo lesion in the right upper back portion of the body ten years after the initial vitiligo lesion. Keywords: Becker's nevus, vitiligo, co-occurrence Öz Vitiligo nedeni tam olarak bilinmeyen, genetik ve genetik olmayan faktörlerin birlikte rol oynadığı edinsel bir bozukluktur. Bu hastalıkta tutulan deride melanositler ortadan kalkar, klinik olarak depigmente makül ve yamalar belirir. Becker nevüs (BN) sıklıkla unilateral dağılım gösteren, keskin ama düzensiz sınırlı hiperpigmente makül, yama veya verrüköz plakların izlendiği, üzerinde değişik derecelerde hipertrikozun bulunduğu bir hastalıktır. Patogenezi belli olmamakla birlikte hamartamatöz bir lezyon olduğu ve üzerinde androjen reseptörlerinin arttığı ileri sürülmektedir.
    [Show full text]
  • Dermoscopy on Nevus Comedonicus: a Case Report and Review of the Literature
    Case report Dermoscopy on nevus comedonicus: a case report and review of the literature Grażyna Kamińska-Winciorek 1, Radosław Śpiewak 2 1The Center for Cancer Prevention and Treatment, Katowice, Poland Head: Beata Wydmańska 2Department of Experimental Dermatology and Cosmetology, Faculty of Pharmacy, Jagiellonian University Medical College, Krakow, Poland Head: Prof. Radosław Śpiewak MD. PhD Postep Derm Alergol 2013; XXX, 4: 252 –254 DOI: 10.5114/pdia.2013.37036 Abstract Nevus comedonicus (NC) is a very rare, benign hamartoma characterised by the occurrence of dilated, comedo-like openings, typically on the face, neck, upper arms, chest or abdomen. In uncertain cases, histopathological exami - nation confirms the diagnosis. The authors suggest dermoscopy as a rapid and useful method of initial diagnosis of nevus comedonicus based upon its distinctive dermoscopic features. The dermoscopy reveals numerous light- and dark-brown, circular or barrel-shaped, homogenous areas with prominent keratin plugs. Key words: dermoscopy, dermatoscopy, nevus comedonicus, epidermal nevus, acne vulgaris. Introduction a hypopigmented, slightly hypotrophic, linear spot of Nevus comedonicus (NC) is a benign hamartoma cha - 2 cm × 8 cm (Figure 1). The plugs could not be extracted racterised by the occurrence of dilated comedo-like open - mechanically. The dermoscopic examination revealed ings, with black or brown keratin plugs, typically localised the distinctive pattern consisting of dark, sharply demar - on the face, neck, upper arms, chest or abdomen. The diag - cated keratin plugs of 1–3 mm diameter, numerous struc - nosis of nevus comedonicus is relatively easy. In uncertain tureless, circular- and barrel-shaped, homogenous areas cases, a typical histopathological picture confirms the diag - with hyperkeratotic plugs of various shades of brown nosis.
    [Show full text]
  • Brain – Necrosis
    Brain – Necrosis 1 Brain – Necrosis 2 Brain – Necrosis Figure Legend: Figure 1 Appearance of a thalamic infarct at low magnification, identified by pallor within the zone of the black arrows, in an F344/N rat. The dentate gyrus of the hippocampus is identified by a white arrow. This infarct was the result of an arterial embolus (arrowhead), shown at higher magnification in Figure 2. Figure 2 Arterial embolus from Figure 1 at higher magnification, in an F344/N rat. Figure 3 Acute necrosis of the posterior colliculus, a bilaterally symmetrical lesion (arrows), in the whole mount of a section in a male F344/N rat from an acute study. This resulted from the selective vulnerability of this brain region to toxin- induced impaired energy metabolism. The arrowhead identifies necrosis of the nucleus of the lateral lemniscus. Figure 4 Similar regionally selective bilateral brain necrosis of the parietal cortex area 1 (blue arrow), thalamus (arrowhead), and retrosplenial cortex (white arrow) in a treated male F344/N rat from an acute study, all resulting from the same toxic compound as used in Figure 3. Figure 5 Unusual form of malacia (total regional necrosis) of the spinal cord in the dorsal spinal funiculi (arrow) in a female F344/N rat from a chronic study. Figure 6 A cortical infarct with gliosis and capillary hyperplasia (arrow) from a male B6C3F1 mouse in a chronic study. Figure 7 A more advanced stage of cortical infarction (arrows) in a treated female B6C3F1 mouse from a chronic chronic inhalation study. Figure 8 Morphology of an infarct of known duration (arrow) in an F344/N rat with experimental infarction.
    [Show full text]
  • The Role of Androgen Receptors in the Clinical Course of Nevus Sebaceus of Jadassohn Katherine S
    The Role of Androgen Receptors in the Clinical Course of Nevus Sebaceus of Jadassohn Katherine S. Hamilton, M.D., Sandra Johnson, M.D., Bruce R. Smoller, M.D. Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee (KSH); and Departments of Dermatology (SJ, BRS) and Pathology (SJ), University of Arkansas for Medical Services, Little Rock, Arkansas During puberty, they usually enlarge and become Nevus sebaceus of Jadassohn (NSJ) is a benign, con- elevated, verrucous, or nodular and may appear genital hamartoma that often presents at birth, ap- brown (1, 2). In late childhood and adulthood, there pears to regress in childhood, and grows during is a significant risk of developing a secondary tu- puberty, suggesting possible hormonal control. We mor, the most common of which are syringocysta- studied 18 cases of NSJ from children and adults for denoma papilliferum and basal cell carcinoma (1, immunohistochemical evidence of androgen recep- 3). Myriad other cutaneous appendageal neoplasms tor expression. The lesions were evaluated for loca- have also been reported to arise within NSJ. tion and pattern of immunostaining, and these Androgen receptors (AR) are nuclear ligand–de- findings were compared between age groups, sexes, pendent transcription factors of the steroid super- and to androgen receptor expression in normal family that bind testosterone and dihydroxytestos- skin. Androgen receptor positivity was seen in the terone (4). AR have been identified in normal sebaceous glands, in eccrine glands with and with- cutaneous structures and in some epithelial tu- out apocrine change, and rarely in keratinocytes in mors. In normal skin, AR have been localized to the sebaceous nevi.
    [Show full text]
  • Choroidal Nevus Transformation Into Melanoma: Analysis of 2514 Consecutive Cases
    CLINICAL SCIENCES Choroidal Nevus Transformation Into Melanoma Analysis of 2514 Consecutive Cases Carol L. Shields, MD; Minoru Furuta, MD; Edwina L. Berman, BS; Jonathan D. Zahler, MD; Daniel M. Hoberman, BS; Diep H. Dinh, BS; Arman Mashayekhi, MD; Jerry A. Shields, MD Objective: To determine features that are predictive of halo absence (P=.009). A mnemonic device to recall risk growth of choroidal nevi into melanoma. factors of ocular melanoma is “To find small ocular mela- noma using helpful hints,” representing thickness, fluid, Methods: This was a retrospective medical record re- symptoms, orange pigment, margin, ultrasonographic hol- view of 2514 consecutive eyes; Kaplan-Meier estimates lowness, and halo absence. The median hazard ratio for and Cox regression analyses were used. those with 1 to 2 risk factors was 3; for 3 or 4 factors, 5; for 5 to 6 factors, 9; and for all 7 factors, 21. Results: The median tumor basal diameter was 5.0 mm and thickness was 1.5 mm. Nevus growth into mela- Conclusions: In an analysis of 2514 choroidal nevi, fac- noma occurred in 2%, 9%, and 13% of eyes at 1, 5, and tors predictive of growth into melanoma included greater 10 years, respectively. Factors predictive of growth into thickness, subretinal fluid, symptoms, orange pigment, melanoma by multivariable analysis included tumor thick- margin near disc, and 2 new features: ultrasonographic ness greater than 2 mm (PϽ.001), subretinal fluid hollowness and absence of halo. (P =.002), symptoms (P =.002), orange pigment (PϽ.001), tumor margin within 3 mm of the optic disc (P=.001), ultrasonographic hollowness (PϽ.001), and Arch Ophthalmol.
    [Show full text]
  • Differentiating Malignant Melanoma from Other Lesions Using Dermoscopy
    PRAXIS Differentiating malignant melanoma from other lesions using dermoscopy Ahmed Mourad Robert Gniadecki MD PhD DMSci ermoscopy (also called dermatoscopy, epilumi- nescent microscopy, or episcopy) is a noninvasive Figure 1. Image depicting proper dermoscopic technique: method of examining skin lesions using a hand- This is a polarized light dermoscope and does not require Dheld magnifying device (a dermoscope) equipped with a direct contact with the skin or application of oil. light source.1 Dermoscopy allows adequate visualization of the structures in the skin not only by magnifying them but also by eliminating the surface light reflection and scatter that obscures the deeper features.2,3 This arti- cle provides information on the dermoscopic features specific to malignant melanoma and other pigmented lesions that often resemble malignant melanoma via naked-eye examination (ie, benign melanocytic nevus [BMN], seborrheic keratosis, and dermatofibroma). Technique Before evaluating the lesion of interest using dermoscopy, the clinician should take an adequate history and evalu- ate the morphology and distribution of the lesion with the naked eye.1 Dermoscopy is then performed by apply- ing the dermoscope on the lesion of interest and looking through the lens to visualize the morphologic features of The presence of 2 or more of the above features sug- the skin lesion (Figure 1). Dermoscopy should never be gests a suspicious lesion that should be biopsied or that used alone, and the dermoscopic result should be corre- the patient should be referred for further assessment.4 lated with that of the naked-eye examination. The cost of a dermoscope ranges from a few hundred Conditions to a few thousand dollars.
    [Show full text]
  • Role of Histopathological Examination in Medicolegal Autopsies in Unravelling Pathology Section Precise Causes of Mortality
    DOI: 10.7860/NJLM/2021/48233:2522 Original Article Role of Histopathological Examination in Medicolegal Autopsies in Unravelling Pathology Section Precise Causes of Mortality DIVYA SHARMA1, ANSHU GUPTA2, KHUSHBOO DEWAN3, KARSING PATIRI4, KUSUM GUPTA5, USHA RANI SINGH6 ABSTRACT Histopathological examination was performed in 96 cases out of Introduction: Medicolegal autopsies are performed to determine which 10 were excluded due to autolysis (n=86). Haemotoxilin the cause and manner of death. Histopathological examination and Eosin (H&E)-stained slides were examined and special is reserved for only those cases where Cause Of Death (COD) is stains and Immunohistochemistry (IHC) applied wherever not readily apparent on autopsy. However, there are conflicting required. Gross and histopathological findings were recorded views regarding the utility of histopathological examination in along with autopsy findings and clinical history. The results were medicolegal cases. tabulated and statistical analysis was done using the Chi-square and Fischer’s test to look for any significance and association Aim: To examine the role of histopathological examination in between gross and microscopic findings in various organs. The unravelling specific causes of mortality in two settings: 1) where p-value of <0.05 was considered significant. collaborative clinical history and gross autopsy findings were available; 2) where definitive cause could be discovered only Results: Histopathological examination was conclusive in at the time of microscopic examination, thus altering its legal ascertaining the specific COD in 30/86 cases (35%). These were implications. categorised as pulmonary causes (27) including one case each Materials and Methods: This was a retrospective observational of fat embolism and Amniotic Fluid Embolism (AFE) and cardiac study including all medicolegal autopsy cases, in which causes (3).
    [Show full text]
  • Lumps & Bumps: Approach to Common Dermatologic Neoplasms
    Case-Based Approach to Common Dermatologic Neoplasms Patrick Retterbush, MD, FAAD Mohs Surgery & Dermatologic Oncology Associate Member of the American College of Mohs Surgery Private Practice: Lockman Dermatology January 27th 2018 Disclosure of Relevant Financial Relationships • I do not have any relevant financial relationships, commercial interests, and/or conflicts of interest regarding the content of this presentation. Goals/Objectives • Recognize common benign growths • Recognize common malignant growths • Useful clues & examination for evaluating melanocytic nevi and when to be concerned for melanoma/atypical moles • How to perform a basic skin biopsy and which method/type to choose • Basic treatment/when to refer Key Questions & Physical Examination Findings for a Growth History Physical Examination • How long has the lesion been • Describing a growth present? – flat or raised? • flat – macule (<1cm) or patch (>1cm) – years, months, weeks • raised – papule (<1cm) or plaque (>1cm) – nodule if deep (majority of lesion in • Has it changed? dermis/SQ) – Size – secondary descriptive features • scaly (hyperkeratosis, retention of strateum – Shape corneum) – Color • crusty (dried serum, blood, or pus on surface) • eroded or ulcerated (partial vs. full thickness – Symptoms – pain, bleeding, itch? epidermal loss) – Over what time frame? • color (skin colored, red, pigmented, pearly) • feel (hard or soft, mobile or fixed) • PMH: • size: i.e. 6 x 4mm – prior skin cancers • Look at the rest of the skin/region of skin • SCC/BCCs vs. melanoma
    [Show full text]
  • Oral and Maxillo-Facial Manifestations of Systemic Diseases: an Overview
    medicina Review Oral and Maxillo-Facial Manifestations of Systemic Diseases: An Overview Saverio Capodiferro *,† , Luisa Limongelli *,† and Gianfranco Favia Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Piazza G. Cesare, 11, 70124 Bari, Italy; [email protected] * Correspondence: [email protected] (S.C.); [email protected] (L.L.) † These authors contributed equally to the paper. Abstract: Many systemic (infective, genetic, autoimmune, neoplastic) diseases may involve the oral cavity and, more generally, the soft and hard tissues of the head and neck as primary or secondary localization. Primary onset in the oral cavity of both pediatric and adult diseases usually represents a true challenge for clinicians; their precocious detection is often difficult and requires a wide knowledge but surely results in the early diagnosis and therapy onset with an overall better prognosis and clinical outcomes. In the current paper, as for the topic of the current Special Issue, the authors present an overview on the most frequent clinical manifestations at the oral and maxillo-facial district of systemic disease. Keywords: oral cavity; head and neck; systemic disease; oral signs of systemic diseases; early diagnosis; differential diagnosis Citation: Capodiferro, S.; Limongelli, 1. Introduction L.; Favia, G. Oral and Maxillo-Facial Oral and maxillo-facial manifestations of systemic diseases represent an extensive and Manifestations of Systemic Diseases: fascinating study, which is mainly based on the knowledge that many signs and symptoms An Overview. Medicina 2021, 57, 271. as numerous systemic disorders may first present as or may be identified by head and https://doi.org/10.3390/ neck tissue changes.
    [Show full text]